Tan WW - Search Results

1

Phase II trial of isoflavone in prostate-specific antigen recurrent prostate cancer after previous local therapy.

Pendleton JM, Tan WW, Anai S, Chang M, Hou W, Shiverick KT, Rosser CJ. Pendleton JM, et al. Among authors: tan ww. BMC Cancer. 2008 May 11;8:132. doi: 10.1186/1471-2407-8-132. BMC Cancer. 2008. PMID: 18471323 Free PMC article. Clinical Trial.

2

A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma.

Jatoi A, Ellison N, Burch PA, Sloan JA, Dakhil SR, Novotny P, Tan W, Fitch TR, Rowland KM, Young CY, Flynn PJ. Jatoi A, et al. Cancer. 2003 Mar 15;97(6):1442-6. doi: 10.1002/cncr.11200. Cancer. 2003. PMID: 12627508 Free article. Clinical Trial.

3

Treatment of men with rising prostate-specific antigen levels following radical prostatectomy.

Tzou K, Tan WW, Buskirk S. Tzou K, et al. Among authors: tan ww. Expert Rev Anticancer Ther. 2011 Jan;11(1):125-36. doi: 10.1586/era.10.210. Expert Rev Anticancer Ther. 2011. PMID: 21166517 Review.

4

Novel agents and targets in managing patients with metastatic prostate cancer.

Tan WW. Tan WW. Cancer Control. 2006 Jul;13(3):194-8. doi: 10.1177/107327480601300306. Cancer Control. 2006. PMID: 16885915 Free article. Review.

5

Quality of life of men with biochemical recurrence of prostate cancer.

Ames SC, Tan WW, Ames GE, Stone RL, Rizzo TD Jr, Heckman MG, Crook JE, Clark MM, Rummans TA, Werch CE. Ames SC, et al. Among authors: tan ww. J Psychosoc Oncol. 2008;26(2):17-34. doi: 10.1300/j077v26n02_02. J Psychosoc Oncol. 2008. PMID: 18285298

6

A phase II trial of 17-allylamino-17-demethoxygeldanamycin in patients with hormone-refractory metastatic prostate cancer.

Heath EI, Hillman DW, Vaishampayan U, Sheng S, Sarkar F, Harper F, Gaskins M, Pitot HC, Tan W, Ivy SP, Pili R, Carducci MA, Erlichman C, Liu G. Heath EI, et al. Clin Cancer Res. 2008 Dec 1;14(23):7940-6. doi: 10.1158/1078-0432.CCR-08-0221. Clin Cancer Res. 2008. PMID: 19047126 Free PMC article. Clinical Trial.

7

A pilot investigation of a multidisciplinary quality of life intervention for men with biochemical recurrence of prostate cancer.

Ames SC, Tan WW, Ames GE, Stone RL, Rizzo TD Jr, Crook JE, Williams CR, Werch CE, Clark MM, Rummans TA. Ames SC, et al. Among authors: tan ww. Psychooncology. 2011 Apr;20(4):435-40. doi: 10.1002/pon.1769. Epub 2010 May 24. Psychooncology. 2011. PMID: 20878861 Clinical Trial.

8

Phase II interventional study (N0337) of capecitabine in combination with vinorelbine and trastuzumab for first- or second-line treatment of HER2-positive metastatic breast cancer: a north central cancer treatment group trial.

Tan WW, Allred JB, Salim M, Flynn P, Fishkin PA, Stella PJ, Wiesenfeld M, Bernath AM, Fitch TR, Perez EA. Tan WW, et al. Clin Breast Cancer. 2012 Apr;12(2):81-6. doi: 10.1016/j.clbc.2012.01.001. Clin Breast Cancer. 2012. PMID: 22444716 Free PMC article. Clinical Trial.

9

Effect of leuprolide on serum amyloid-β peptide levels and memory in patients with prostate cancer with biochemical recurrence.

Tan WW, Heckman MG, Vishnu P, Crook JE, Younkin LH, Covil EG, Ferman TJ, Graff-Radford NR, Younkin SG, Smallridge RC, Wehle MJ, Buskirk SJ. Tan WW, et al. Urology. 2013 Jan;81(1):150-4. doi: 10.1016/j.urology.2012.08.066. Urology. 2013. PMID: 23273081

10

Changing paradigms in management of metastatic Castration Resistant Prostate Cancer (mCRPC).

Gupta E, Guthrie T, Tan W. Gupta E, et al. BMC Urol. 2014 Jul 25;14:55. doi: 10.1186/1471-2490-14-55. BMC Urol. 2014. PMID: 25062956 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

132 results

Search Page